Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells.
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report.
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
Berlex continues legal challenge to FDA over MS drug.
Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients.
Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?
Interferon-β-1b: a review of its use in multiple sclerosis.
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter.
Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial.
β-Amyloid: Enemy or Remedy?
Combination therapy of interferon Beta-1b and tacrolimus: a pilot safety study.
Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication.
Insight into the mechanism of laquinimod action.
A gender gap in autoimmunity.
Regulation of prefrontal cortex myelination by the microbiota.
Masitinib is being investigated in the treatment of amyotrophic lateral sclerosis (ALS)
Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians.
Study of teriflunomide in reducing the frequency of relapses and accumulation of disability in patients with multiple sclerosis (TEMSO)
Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro.

Pages